Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at capecitabine and aflibercept for bowel cancer that has spread elsewhere in the body (CAPITAL)

Overview

Cancer types:

Bowel (colorectal) cancer, Colon cancer, Rectal cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at 2 drugs called capecitabine and aflibercept for people who have bowel cancer that has spread elsewhere in the body.

Recruitment start: 31 March 2014

Recruitment end: 31 December 2018

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Paul Ross

Supported by

Experimental Cancer Medicine Centre (ECMC)

Guy's and St Thomas' NHS Foundation Trust

Sanofi Aventis

Last reviewed: 02 Jan 2019

CRUK internal database number: 11777

Help and support